feed,title,long_url,short_url
Benzinga,Valneva-Pfizer Choose Three-Dose Schedule For Use In Adults Moving Forward,https://benzinga.com/general/biotech/22/02/25419181/valneva-pfizer-choose-three-dose-schedule-for-use-in-adults-moving-forward,https://bit.ly/3LbPH7K
Benzinga,Spectrum Brands Clocks 2.9% Sales Growth In Q1; Notes Margin Pressure,https://benzinga.com/news/earnings/22/02/25418640/spectrum-brands-clocks-2-9-sales-growth-in-q1-notes-margin-pressure,https://bit.ly/3Hu0JDe
